Mugglehead Investment Magazine

All posts tagged "C"

Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data

Medical and Pharmaceutical

Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data

The biotech operator's lung cancer drug enabled 16-month progression-free survival among patients

Rowan DunneJune 23, 2025

Alternative Energy

The Mugglehead technology roundup: into the future edition

Today's edition of the Mugglehead technology roundup features five companies with five unique value propositions, each representing significant opportunities to buy the dip.

Joseph MortonJune 14, 2022

Mugglehead Investment Magazine

All posts tagged "C"

Medical and Pharmaceutical

Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data

Alternative Energy

The Mugglehead technology roundup: into the future edition

Most Read

Mining

Trigg Minerals pulls C$11.1 million together to advance Antimony Canyon project

News

China’s #1 antimony smelter is shutting down this month: report

Gold

Blue Gold soars on Nasdaq listing and newly announced expansion ambitions

Cannabis

LEEF Brands prepares to harvest over 1 million cannabis plants

Mining

U.S. Antimony restarts mining activities near only American smelter